Dexcom, Inc. reported preliminary unaudited revenue guidance for the fourth quarter ended December 31, 2021, for the fiscal year 2021 and revenue guidance for the fiscal year 2022. For the quarter, the company expects the revenue to be approximately $698 million, an increase of 23% over the fourth quarter of 2020.
For the fiscal year 2021, the company expects the total preliminary, unaudited revenue to be approximately $2.448 billion, an increase of more than 27% over 2020.
For the fiscal year 2022, the company expects the revenue to be in the range of $2.82 billion to $2.94 billion. Representing expected growth of approximately 15% to 20% over 2021.